Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines
Ai‐ris Y. Collier, Jingyou Yu, Katherine McMahan, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 21, pp. 2010-2012
Open Access | Times Cited: 177

Showing 1-25 of 177 citing articles:

Humoral and cellular immune memory to four COVID-19 vaccines
Zeli Zhang, José Mateus, Camila H. Coelho, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2434-2451.e17
Open Access | Times Cited: 444
Covid-19 Vaccines — Immunity, Variants, Boosters
Dan H. Barouch
New England Journal of Medicine (2022) Vol. 387, Iss. 11, pp. 1011-1020
Open Access | Times Cited: 378
Modeling transmission of SARS-CoV-2 Omicron in China
Jun Cai, Xiaowei Deng, Juan Yang, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1468-1475
Open Access | Times Cited: 251
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 214
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
Kirsten E. Lyke, Robert L. Atmar, Clara Domínguez Islas, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 7, pp. 100679-100679
Open Access | Times Cited: 144
GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine
Ieva Čiučiulkaitė, Birte Möhlendick, Laura Thümmler, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 132
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 10, pp. 951-963
Open Access | Times Cited: 116
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
Zabrina L. Brumme, Francis Mwimanzi, Hope R. Lapointe, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 84
Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms
Caroline Atyeo, Lydia L. Shook, Sara Brigida, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 75
Vaccine protection against the SARS-CoV-2 Omicron variant in macaques
Abishek Chandrashekar, Jingyou Yu, Katherine McMahan, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1549-1555.e11
Open Access | Times Cited: 71
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 63
COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research
Lindsey Wang, David C. Kaelber, Rong Xu, et al.
Blood Reviews (2022) Vol. 54, pp. 100931-100931
Open Access | Times Cited: 64
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients
Michel Obéid, Madeleine Suffiotti, Céline Pellaton, et al.
JAMA Oncology (2022) Vol. 8, Iss. 5, pp. e220446-e220446
Open Access | Times Cited: 62
Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
Chen Tan, Ai‐ris Y. Collier, Jingyou Yu, et al.
JAMA Network Open (2022) Vol. 5, Iss. 8, pp. e2226335-e2226335
Open Access | Times Cited: 55
Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge
Jennifer M. Polinski, Andrew R. Weckstein, Michael Batech, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e222959-e222959
Open Access | Times Cited: 51
Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant
Jinyan Liu, Abishek Chandrashekar, Daniel Sellers, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 47
Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens
Lynda Coughlan, Eric J. Kremer, Dmitry M. Shayakhmetov
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1822-1849
Open Access | Times Cited: 44
Vaccination and immunotherapies in neuroimmunological diseases
Alexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 5, pp. 289-306
Open Access | Times Cited: 42
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections
Salomé Desmecht, Aleksandr Tashkeev, Majdouline El Moussaoui, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
COVID‐19 and plasma cells: Is there long‐lived protection?*
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 41
The role of vaccines in the COVID-19 pandemic: what have we learned?
Florian Krammer
Seminars in Immunopathology (2023) Vol. 45, Iss. 4-6, pp. 451-468
Open Access | Times Cited: 38
Decline of Humoral and Cellular Immune Responses Against SARS-CoV-2 6 Months After Full BNT162b2 Vaccination in Hospital Healthcare Workers
Benjamin Bonnet, Hélène Chabrolles, Christine Archimbaud, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top